Atlas Trials

Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects

Clinical trial NCT01057927 · COMPLETED

Trial details

NCT number
NCT01057927
Sponsor
Oxagen Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2007-01-01
Primary completion
2007-11-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.